La trajectoire des symptômes dépressifs de l'enfance à l'adolescence et les cibles d'intervention préventive

Marcotte, Diane; Lemieux, Annie

doi:10.1590/1413-81232014193.16072013

Cited by 7 publications

(9 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This instrument has been translated into many languages, including French, validated through back-translations and test-retest reliability. This validated French version of the BDI-II was shown to accurately diagnose depression in human studies in France [ 26 , 27 ], Belgium [ 28 ], and Canada [ 29 – 31 ]. We previously adapted and validated this French version of the BDI-II in Cameroon [ 17 ]; and in our current study, this psychometric test was used to identify the presence and severity of depression.…”

Section: Methodsmentioning

confidence: 99%

Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects

et al. 2017

View full text Add to dashboard Cite

Following global efforts to increase antiretroviral therapy (ART) access in Sub-Saharan Africa, ART coverage among HIV-infected Cameroonians increased from 0% in 2003 to 22% in 2014. However, the success of current HIV treatment programs depends not only on access to ART, but also on retention in care and good treatment adherence. This is necessary to achieve viral suppression, prevent virologic failure, and reduce viral transmission and HIV/AIDS-related deaths. Previous studies in Cameroon showed poor adherence, treatment interruption, and loss to follow-up among HIV+ subjects on ART, but the factors that influence ART adherence are not well known. In the current cross-sectional study, patient/self-reported questionnaires and pharmacy medication refill data were used to quantify ART adherence and determine the factors associated with increased risk of non-adherence among HIV-infected Cameroonians. We demonstrated that drug side-effects, low CD4 cell counts and higher viral loads are associated with increased risk of non-adherence, and compared to females, males were more likely to forego ART because of side effects (p<0.05). Univariate logistic regression analysis demonstrated that subjects with opportunistic infections (on antibiotics) had 2.42-times higher odds of having been non-adherent (p<0.001). Multivariable analysis controlling for ART regimen, age, gender, and education showed that subjects with opportunistic infections had 3.1-times higher odds of having been non-adherent (p<0.0003), with significantly longer periods of non-adherence, compared to subjects without opportunistic infections (p = 0.02). We further showed that compared to younger subjects (≤40 years), older subjects (>40 years) were less likely to be non-adherent (p<0.01) and had shorter non-adherent periods (p<0.0001). The presence of depression symptoms correlated with non-adherence to ART during antibiotic treatment (r = 0.53, p = 0.04), and was associated with lower CD4 cell counts (p = 0.04) and longer non-adherent periods (p = 0.04). Change in ART regimen was significantly associated with increased likelihood of non-adherence and increased duration of the non-adherence period. Addressing these underlying risk factors could improve ART adherence, retention in care and treatment outcomes for HIV/AIDS patients in Cameroon.

show abstract

Section: Methodsmentioning

confidence: 99%

Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects

et al. 2017

View full text Add to dashboard Cite

show abstract

“…This instrument has been translated into many languages, including French, validated through back-translations and test-retest reliability. This validated French version of the BDI-II was shown to accurately diagnose depression in human studies in France [ 33 , 34 ], Belgium [ 35 ], and Canada [ 36 – 38 ]. We previously adapted and validated this French version of the BDI-II in Cameroon [ 25 ], and in our current study, this psychometric test was used to detect depression and assess its severity.…”

Section: Methodsmentioning

confidence: 99%

Depressive symptoms in HIV-infected and seronegative control subjects in Cameroon: Effect of age, education and gender

et al. 2017

View full text Add to dashboard Cite

Depression is a leading cause of HIV/AIDS disease burden; it worsens health outcomes and quality of life. Addressing this problem requires accurate quantification of the extra burden of depression to HIV/AIDS in a given population, and knowledge of the baseline depression prevalence in the general population. There has been no previous study of depression in the general Cameroonian population. The current study attempts to address that important need. We used the Beck Depression Inventory-II to assess the prevalence and severity of depressive symptoms in 270 HIV-infected and seronegative Cameroonians. Univariate analyses showed a trend toward higher depressive symptoms among cases, compared to controls (p = 0.055), and among older subjects (>40 years), compared to younger subjects (≤40 years) (p = 0.059). Analysis of depression severity showed that 33.73% of cases had moderate-to-severe depressive symptoms, compared to 19.8% of controls (p<0.01). However, multivariable negative binomial regression analyses showed no effect of age, HIV status, CD4 levels, viral loads, ART, or opportunistic infections on the risk of depressive symptoms. Both univariate and multivariable regression analyses showed significantly higher risk of depressive symptoms among females compared to males; this was significant for both female controls and female cases. Female cases had significantly higher CD4 cell counts and lower viral loads, compared to males. Both univariate and multivariable regression analyses showed that lower education (≤10 years) was associated with increased risk of depressive symptoms. This study shows a high prevalence of depressive symptoms among seronegative controls and HIV-infected Cameroonians. Integrating care for mental disorders such as depression into primary health care and existing HIV/AIDS treatment programs in Cameroon may improve the wellbeing of the general population and could lower the HIV/AIDS burden.

show abstract

“…Chez les filles, une évolution inverse est présente, à savoir que les symptômes cognitifs augmentent jusqu'à l'âge de 15 ans, suivis d'une diminution. Ce résultat permet de constater que le fait que certaines études n'aient observé aucune augmentation des symptômes chez les garçons (ex : Marcotte & Lemieux, 2014;Rawana & Morgan, 2014) ne serait probablement pas représentatif de l'ensemble des symptômes. La catégorie des symptômes cognitifs est toutefois l'unique catégorie qui présente une augmentation chez les garçons, bien que l'on ÉVOLUTION DES CATÉGORIES DE SYMPTÔMES observe également une tendance à une augmentation pour la catégorie des symptômes affectifs de l'examen des moyennes.…”

Section: Discussionunclassified

Évolution des catégories de symptômes de dépressifs au cours de l’adolescence et de l’émergence de l’âge adulte et étude des différences entre étudiants au postsecondaire et non-étudiants.

Lapierre¹,

Marcotte²

2024

Canadian Journal of Behavioural Science / Revue canadienne des

Self Cite

View full text Add to dashboard Cite

Les symptômes dépressifs augmentent au cours de l’adolescence et l’émergence de l’âge adulte (EAA; Schubert et al., 2017). L’évolution des symptômes de dépression considérés individuellement ou en catégorie lors de cette période est toutefois peu étudiée. Au cours de l’EAA, les différents parcours scolaires des individus ont peu étudié en ce qui a trait aux symptômes dépressifs. Les objectifs de la présente étude sont : 1) évaluer les trajectoires d’évolution des différents types de symptômes dépressifs (c.-à-d. cognitifs, affectifs et somatiques) entre l’âge de 11 à 19 ans. 2) évaluer les différences entre étudiants et non-étudiants sur les différents types de symptômes dépressifs entre 17 et 19 ans. À cet effet, 499 étudiants ont complété des mesures annuelles entre l’âge de 11 à 19 ans. les symptômes ont été mesurés à l’aide de l’Inventaire de dépression de Beck, 2e édition (Beck et al., 1996). La typologie utilisée pour évaluer les types de symptômes est celle proposée par Beck et al. (2002). les symptômes affectifs et somatiques suivent une augmentation significative au cours de la période 11 à 19 ans. Des différences de genre importantes sont observées sur les trajectoires d’évolution. Pour la période 17–19 ans, des différences importantes sont observées selon le genre et le statut scolaire. Les garçons qui entreprennent des études postsecondaires présentent une augmentation significative des symptômes cognitifs et affectifs de la dépression.

show abstract

La trajectoire des symptômes dépressifs de l'enfance à l'adolescence et les cibles d'intervention préventive

Abstract: La trajectoire des symptômes dépressifs de l'enfance à l'adolescence et les cibles d'intervention préventiveA trajetória dos sintomas depressivos da infância para a adolescência e objetivos da intervenção preventiva

Cited by 7 publications

References 22 publications

Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects

Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects

Depressive symptoms in HIV-infected and seronegative control subjects in Cameroon: Effect of age, education and gender

Évolution des catégories de symptômes de dépressifs au cours de l’adolescence et de l’émergence de l’âge adulte et étude des différences entre étudiants au postsecondaire et non-étudiants.

Contact Info

Product

Resources

About